Uipath, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
PATH
Uipath, INCRaghavendra Malpani, CPO & CTO of UiPath, Inc., reported a transaction involving the withholding of shares to cover tax obligations related to vested performance and restricted stock units.
NYSE
PATH
Uipath, INCUiPath Chief Accounting Officer Hitesh Ramani reports transactions involving Class A Common Stock, including shares withheld for tax obligations.
NYSE
PATH
Uipath, INCUiPath Chief Accounting Officer Hitesh Ramani reports transactions involving Class A Common Stock, including shares withheld for tax obligations.
NYSE
PATH
Uipath, INCUiPath, Inc. executive Ashim Gupta reported transactions involving Class A Common Stock, including shares withheld for tax obligations.
NYSE
PATH
Uipath, INCUiPath GC & Chief Legal Officer Brad Brubaker reported transactions involving Class A Common Stock, including shares withheld for tax obligations and purchases through an employee stock plan.
NYSE
PATH
Uipath, INCUiPath, Inc. director Karenann K. Terrell has reported the acquisition of 19,175 Restricted Stock Units (RSUs) as part of the company's non-employee director compensation policy.
NYSE
PATH
Uipath, INCUiPath Director Philippe Botteri acquired 19,175 Restricted Stock Units (RSUs) as part of the company's non-employee director compensation policy.
NYSE
PATH
Uipath, INCUiPath, Inc. director Rich Wong received a grant of 19,175 Restricted Stock Units (RSUs) on June 25, 2026, as part of the company's non-employee director compensation policy.
NYSE
PATH
Uipath, INCUiPath, Inc. director Daniel D. Springer was granted 19,175 Restricted Stock Units (RSUs) on June 25, 2026, as part of the company's non-employee director compensation policy.
NYSE
PATH
Uipath, INCUiPath, Inc. director Michael Lawrence Gordon was granted 19,175 Restricted Stock Units (RSUs) on June 25, 2026, as part of the company's non-employee director compensation policy.
NYSE
PATH
Uipath, INCUiPath, Inc. reports a stock grant to Director June Yang, comprising Restricted Stock Units vesting over time, as disclosed in a Form 4 filing.
NYSE
PATH
Uipath, INCUiPath's CPO & CTO, Raghavendra Malpani, reported a series of transactions involving Class A Common Stock, including shares withheld for tax obligations and newly acquired RSUs.
NYSE
PATH
Uipath, INCUiPath's General Counsel and Chief Legal Officer, Brad Brubaker, reported the acquisition of 157,208 restricted stock units and the disposal of shares for tax obligations.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, reported the acquisition of 123,466 restricted stock units and the disposition of shares for tax obligations.
NYSE
PATH
Uipath, INCUiPath's Chief Operating and Financial Officer, Ashim Gupta, reported the acquisition of 306,748 restricted stock units and the disposition of 79,589 shares for tax obligations.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines reported the transfer of over 9.6 million Class A Common Stock shares due to a divorce settlement, retaining voting rights but relinquishing pecuniary interest.
NYSE
PATH
Uipath, INCUiPath's Chief Operating and Financial Officer, Ashim Gupta, reported the acquisition of 288,321 Class A Common Stock shares through the vesting of performance-based restricted stock units.
NYSE
PATH
Uipath, INCUiPath's General Counsel and Chief Legal Officer, Brad Brubaker, increased his beneficial ownership by 145,985 shares of Class A Common Stock through the earning of performance-based restricted stock units.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, reported the vesting of 31,021 performance-based restricted stock units.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines executed planned sales of Class A Common Stock totaling 135,000 shares over three days in late January 2026 under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $15.3753 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $15.68 per share under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $773,208 as part of a pre-arranged trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines reported the sale of 45,000 Class A Common Stock shares at an average price of $16.6096, executed under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $17.17 per share on January 9, 2026, under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock on January 8, 2026, under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $17.32 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, had 24,968 shares withheld by the company to cover tax obligations related to RSU vesting.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, filed an amended Form 4 to correct a clerical error in his reported beneficial ownership of Class A Common Stock.
NYSE
PATH
Uipath, INCUiPath's GC & Chief Legal Officer, Brad Brubaker, reported a disposition of 34,843 shares for tax obligations and an ESPP purchase.